» Articles » PMID: 11943704

Clonal Human (hNT) Neuron Grafts for Stroke Therapy: Neuropathology in a Patient 27 Months After Implantation

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2002 Apr 12
PMID 11943704
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Although grafted cells may be promising therapy for stroke, survival of implanted neural cells in the brains of stroke patients has never been documented. Human NT2N (hNT) neurons derived from the NTera2 (NT2) teratocarcinoma cell line were shown to remain postmitotic, retain a neuronal phenotype, survive >1 year in host rodent brains and ameliorate motor and cognitive impairments in animal models of ischemic stroke. Here we report the first postmortem brain findings of a phase I clinical stroke trial patient implanted with human hNT neurons adjacent to a lacunar infarct 27 months after surgery. Neurofilament immunoreactive neurons were identified in the graft site, fluorescent in situ hybridization revealed polyploidy in groups of cells at this site just like polyploid hNT neurons in vitro, and there was no evidence of a neoplasm. These findings indicate that implanted hNT neurons survive for >2 years in the human brain without deleterious effects.

Citing Articles

Relationship Between Location of Cell Transplantation and Recovery for Intracerebral Stem Cell Transplantation for Chronic Traumatic Brain Injury: Analysis of STEMTRA Trial.

Kawabori M, Karasawa Y, Suenaga J, Nakamura H, Imai H, Yasuhara T Neurotrauma Rep. 2025; 6(1):106-114.

PMID: 39990703 PMC: 11839542. DOI: 10.1089/neur.2024.0130.


PLCβ1 by-passes early growth response -1 to induce the differentiation of neuronal cells.

Gonzalez-Burguera I, Lin G, Lopez de Jesus M, Saumell-Esnaola M, Barrondo S, Garcia Del Cano G Cell Death Discov. 2024; 10(1):250.

PMID: 38789419 PMC: 11126630. DOI: 10.1038/s41420-024-02009-z.


Muse cells: ushering in a new era of stem cell-based therapy for stroke.

Li H, Wei J, Liu X, Zhang P, Lin J Stem Cell Res Ther. 2022; 13(1):421.

PMID: 35986359 PMC: 9389783. DOI: 10.1186/s13287-022-03126-1.


Whole-genome analysis of human embryonic stem cells enables rational line selection based on genetic variation.

Merkle F, Ghosh S, Genovese G, Handsaker R, Kashin S, Meyer D Cell Stem Cell. 2022; 29(3):472-486.e7.

PMID: 35176222 PMC: 8900618. DOI: 10.1016/j.stem.2022.01.011.


Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.

Rahman M, Islam M, Islam M, Harun-Or-Rashid M, Islam M, Abdullah S Biology (Basel). 2022; 11(1).

PMID: 35053145 PMC: 8772847. DOI: 10.3390/biology11010147.


References
1.
Zigova T, Barroso L, Willing A, Saporta S, McGrogan M, Freeman T . Dopaminergic phenotype of hNT cells in vitro. Brain Res Dev Brain Res. 2000; 122(1):87-90. DOI: 10.1016/s0165-3806(00)00055-9. View

2.
Fink J, Schumacher J, Ellias S, PALMER E, Saint-Hilaire M, Shannon K . Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant. 2000; 9(2):273-8. DOI: 10.1177/096368970000900212. View

3.
Lee V, Hartley R, Trojanowski J . Neurobiology of human neurons (NT2N) grafted into mouse spinal cord: implications for improving therapy of spinal cord injury. Prog Brain Res. 2000; 128:299-307. DOI: 10.1016/S0079-6123(00)28027-8. View

4.
Freeman T, Cicchetti F, Hauser R, Deacon T, Li X, Hersch S . Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A. 2000; 97(25):13877-82. PMC: 17669. DOI: 10.1073/pnas.97.25.13877. View

5.
Saporta S, Willing A, Colina L, Zigova T, Milliken M, Daadi M . In vitro and in vivo characterization of hNT neuron neurotransmitter phenotypes. Brain Res Bull. 2000; 53(3):263-8. DOI: 10.1016/s0361-9230(00)00329-4. View